Political focus on economy and trade, as well as attention on food security/climate change/population growth has led to an increased awareness of the role that biotechnology can play in United Kingdom
THIS REPORT CONTAINS ASSESSMENTS OF COMMODITY AND TRADE ISSUES MADE BY
USDA STAFF AND NOT NECESSARILY STATEMENTS OF OFFICIAL U.S. GOVERNMENT
Required Report - public distribution
GAIN Report Number:
Agricultural Biotechnology Annual
UK GE Plants and Animals Report
Political focus on economy and trade, as well as attention on food security/climate change/population
growth has led to an increased awareness of the role that biotechnology can play in United Kingdom
(UK) access to biotechnology. The UK is a strong proponent of more efficient and effective regulation
of genetically engineered crops within Europe. Increasing global adoption of biotech, and EU
restrictions on unapproved biotech events in the food and animal feed chains are affecting the
availability and the cost of non-biotech ingredients. In light of this, supermarket chains are reviewing
their policies and changes in favor of biotech have taken place. In time, the food industry may have
greater confidence to incorporate more products of genetically engineered crops in the supply chain.
Table of Contents
Section I. Executive Summary:................................................................................................... - 3 -
Section II. Plant Biotechnology Trade and Production: ............................................................. - 4 -
Production ............................................................................................................................... - 5 -
Trade ....................................................................................................................................... - 6 -
Section III. Plant Biotechnology Policy: .................................................................................... - 9 -
Responsible UK authorities .................................................................................................. - 10 -
Recent statements by Secretary of State for Environment, Food, and Rural Affairs ........... - 10 -
UK Government .................................................................................................................... - 11 -
Agri-tech Strategy ................................................................................................................. - 12 -
Role and membership of the Biosafety Committee .............................................................. - 12 -
Political factors ..................................................................................................................... - 13 -
Approvals for food/feed and cultivation ............................................................................... - 13 -
Biotechnology Crops Approved for Commercial Use .......................................................... - 13 -
Field testing of biotechnology crops ..................................................................................... - 13 -
Coexistence between biotech and non-biotech crops (including organic agriculture) ......... - 14 -
Example of to How to Label for Food Produced from GMOs ............................................. - 15 -
Labeling for Genetically Modified Microorganisms (GMMs) and “Processing Aids” ........ - 16 -
Seed Labeling Legislation..................................................................................................... - 16 -
Section IV. Plant Biotechnology Marketing Issues: ................................................................. - 16 -
UK Consumer Research into Attitudes and Acceptance of Biotech foods ........................... - 17 -
Section V. Plant Biotechnology Capacity Building and Outreach: .......................................... - 18 -
Section VI. Animal Biotechnology: .......................................................................................... - 18 -
- 2 -
Section I. Executive Summary:
Disclaimer: This report presents analysis and views of the author and does not reflect the official views
of the U.S. Department of Agriculture (USDA).
1. The United Kingdom (UK) is a member of the European Union (EU) and this report should be read in
conjunction with the EU Annual Agricultural Biotechnology Report, coordinated by the Foreign
Agricultural Service in Paris, France. The EU Report (FR9105), is available here: GAIN database link
2. The term “agricultural biotechnology” refers to an evolving continuum of technologies. It is a broadly
applied term that may or may not refer to crops developed through recombinant DNA technologies, i.e.,
“plant biotechnology,” “GMO”, “transgenic,” “biotech crops,” or genetically engineered (GE) crops.
3. USDA uses the terms biotechnology or genetically engineered (GE) in addressing this topic.
However, the European Union legislation and Member State implementing regulations refer to
Genetically Modified (GM) food and feed and Genetically Modified Organisms (GMO). These terms
are used in this report when discussing EU legislation and UK implementation.
A focus on the economy and trade (particularly in light of forthcoming negotiations on a Transatlantic
Trade and Investment Partnership between the United States and the EU) has made a stronger political
case for UK access to the products of genetic engineering. Recent statements by the Environment, Food
and Rural Affairs Minister are clearly designed to indicate to technology companies that the UK is
‘open for business.’ In addition, the UK government is keen to make the European Union regulatory
system governing genetically engineered (GE) crops “more efficient and more effective”.
The UK has some of the largest and most efficient farms in Europe, but recent extreme weather events
and a reduction in available fungicides and pesticides (as a result of an EU review) has left horticultural
production vulnerable. The UK is keen to attract inward investment in plant science applications and
capitalize on any growth opportunities presented by agricultural biotechnology.
As a policy response, the UK is developing a long-term agri-tech strategy focused on knowledge
transfer and the application of technology to the agricultural sector. An initial indication of its scope is
- 3 -
expected by mid 2013.
Despite the fact that the UK feed and livestock industries are protein-deficient, trade in these products
continues to be erratic. Confidence to trade is wholly dependent on EU approval (for food and feed) for
new GE crops grown outside the EU in the main supplier countries of Argentina, Brazil and USA. Low
Level Presence (LLP) of unapproved GE events in bulk shipments remains a concern that dominates
trade decisions, since the threshold for feed is very low at 0.1 percent (only for traits already in the EU
approval pipeline) and continues to be zero tolerance for the food supply chain.
UK political leadership on this issue may give greater confidence to the food industry to incorporate
more products of genetic engineering in the food chain. There is an increasing global adoption of
biotech in crop production, a zero tolerance of unapproved biotech events in the food chain, and an
extremely low tolerance in animal feed (0.1 percent) within EU law. These factors are affecting the
availability and cost of non-biotech ingredients to the extent that several major supermarket chains and
foodservice suppliers are reviewing their policies. This is creating a more favorable market for biotech
animal feed. Incorporation of ingredients derived from biotech crops is happening on a case-by-case
basis so that the cost-benefit analysis to consumers is clear.
As regards consumer acceptance for biotechnology, there is a vocal minority opposed. However, most
surveys show apathy and lack of knowledge by the general population, who rely heavily on supermarket
chains to provide them with safe, quality food. There is a dominance of private label products in the
UK market and an inherent trust (cultivated by the retailers) that they will “do the right thing” for their
Generally, there are signs that the ground is shifting in the UK. Trade and even the mainstream media is
increasingly making a case for the technology and calling on industry and the public to be more open-
minded about potential benefits. There is a growing awareness that European consumers are buying
meat from animals fed on biotech feed, and a growing acceptance that biotech crop derivatives in the
food supply chain are inevitable, and to be managed, if not embraced.
Section II. Plant Biotechnology Trade and Production:
- 4 -
Despite being a supporter of the science, the UK has never planted a commercial biotech crop, and has
no crops under development. The limited portfolio of plant biotech events that are approved for
cultivation in the EU are not well-suited to UK growing conditions. However, the UK government is
keen to support domestic horticultural production and crop improvement and is supportive of the use of
genetic engineering to achieve beneficial outcomes in crop research and development.
The private sector's interest in developing varieties of biotech plants suitable for UK and wider EU
cultivation has waned. Almost all of the nearly 60 crop trials conducted in the UK since 2000 have been
subject to vandalism, and this, together with the uncertainty and delays characteristic of the EU approval
process, amounts to an unattractive investment.
In 2012, Rothamsted Research embarked on a field trial of Cadenza wheat, modified to produce a non-
toxic odor - (E) beta-farnesene (EBF) (a naturally occurring chemical found in peppermint plants) that
the wheat releases to act as an alarm signal to keep aphids away and attract their native predators,
parasitic wasps (Braconidae). Project details are available here: Rothamsted Research
This is a publicly funded research trial, Rothamsted Research receives UK government funding via the
Biotechnology and Biological Sciences Research Centre (BBSRC). Despite action by protestors, the
trial continued amid tight security, was successfully harvested, and was of sufficient quality to yield
results. Outreach by Rothamsted scientists, who appealed through video, radio and the web for their
work to continue, largely won the hearts and minds of the British population. This trial is expected to
proceed again in 2013.
In addition, the UK has recently completed publicly funded field trials of potato lines genetically
modified for resistance to late blight and for nematode resistance. In 2007, a large private biotechnology
company undertook a field trial with late blight resistant potatoes. It was destroyed in 2007, but
completed successfully in 2008. Despite this, that company decided to halt field trials in the UK, citing
delays in the EU approval process and a review of returns on its investment within Europe for its
portfolio as a whole.
Potato blight (the cause of the potato famine in Ireland) is probably the most devastating crop disease in
British agriculture and costs UK growers USD 32 million per year in fungicides to keep it in check. The
removal of approval for some pesticides, as part of an EU review, has compounded the problem.
Despite a long road ahead for commercialization of any late blight resistant potato within Europe, the
UK government and farming industry will be keen to explore the cultivation of plants with this
characteristic. If the seed line has been developed with public money, as in the case of the current late
blight resistant potato trial in Ireland, public acceptance may be more easily won.
- 5 -
There are strong historic and cultural ties between the UK and the United States, which are obvious in
consumer trends in retail and foodservice markets.
In recent years, the UK has increasingly imported more horticultural products and consumer-ready food
and drink products as opposed to bulk and intermediate agricultural products from the USA. The de
facto closure of large swathes of the UK market after implementation of the EU's biotechnology
regulations in 2004 (Regulation 1829/2003) affected bulk/lightly processed commodities, such as animal
feed components: soybean meal, and corn products such as Distillers Dried Grains (DDGS) and corn
gluten feed (CGF), in particular. Despite the fact that the UK feed and livestock industries are protein-
deficient, trade in these products continues to be erratic. Confidence to trade is wholly dependent on EU
approval (for food and feed) for new biotech crops grown outside the EU in the main supplier countries
of Argentina, Brazil and the United States. Low Level Presence (LLP) of unapproved biotech events in
bulk shipments remains a concern that dominates trade decisions, since the threshold for feed is very
low at 0.1 percent (and only for traits already in the EU approval pipeline) and continues to be zero
tolerance for the food supply chain.
For over a decade, U.S. exports of processed foods and beverages have also been constrained by market
conditions and EU legislation pertaining to GM foods. As a result of the pervasive negative image of
biotechnology, UK supermarkets and food manufacturers formulate their regular grocery products to
exclude biotech ingredients. Usually the biotech element of processed foods is a small component of the
overall product, for example, soy lecithin (used as an emulsifier). This means that the additional cost of
sourcing non-biotech ingredients adds only a small contribution to the finished price of the goods.
However, for many U.S. companies, the additional burden to source non-biotech ingredients to supply
the EU is often too large a hurdle to overcome. This is also increasingly the case for other countries
wishing to supply the EU. Since 28 countries now produce biotech crops it is becoming ever-harder to
source non-biotech ingredients.
As can be seen from the chart below, soybean meal is of significant importance to UK livestock
industries. Imports of whole soybeans are fairly steady, since there is only one UK processing plant.
- 6 -
UK Soybean and Soybean Meal Imports, Last Ten Marketing Years in Metric Tons
Data source: GTIS/UK HMRC
The next chart shows the erratic price and confidence-driven buying pattern from the United States.
Adoption of biotech traits, and their asynchronous EU approval, has clearly affected U.S. exports to the
- 7 -
UK Imports of Soybeans and Soybean Meal from U.S. 2002/03 to 2011/12
Data source: GTIS/UK HMRC
Without change in the EU approval process, this trade pattern will continue for U.S. product and may be
repeated in imports from Brazil, Argentina and other non-EU countries, as they adopt new biotech traits
that may not yet be approved or which never seek approval in the EU.
Confidence, provided by EU approval, also dictates trade in Distillers Dried Grains (DDGs) and Corn
Gluten Feed (CGF) from the U.S. Price is also an overriding factor, and the U.S. has had bumper corn
harvests until the drought affected yields last year.
As illustrated by the below chart (data from U.S. Grains Council), the last few years have seen a return
to UK imports of DDGs and CGF from the United States. However, there is UK industry concern that
corn varieties planted in the U.S. in 2013 may not make it through the EU approval system in time for
marketing year 2013/14.
- 8 -
UK Imports of Distillers Dried Grains and Corn Gluten Feed from U.S. 2007 to 2011
Source: U.S. Grains Council
Since the late 1990s/early 2000s, U.S. exports of processed foods and beverages have also been
constrained by market conditions and EU legislation on genetic engineering. As a result of a pervasive
negative image, UK supermarkets and food manufacturers formulate their regular grocery products to
exclude biotech ingredients. Usually the biotech element of processed foods is a small component of
the overall product. This means that the additional cost of sourcing non-biotech ingredients adds only a
small contribution to the finished price of the goods. However, for many U.S. companies, the additional
burden to source non-biotech ingredients to supply the EU is often too large a hurdle to overcome. Soy
and corn-based products are particularly affected, but those containing glucose or other sugar
components of biotech sugar beet or oilseed rape (Canola) must also label, and by doing so may not be
listed or carried in UK inventories.
There are examples of products overcoming the hurdles, labeling appropriately and achieving sales
success. These products are usually those where consumers have a desire for the product or there is a
price incentive that counters the presence of biotech ingredients, for example, candy bars and oils.
Section III. Plant Biotechnology Policy:
- 9 -
As a Member State, the UK must implement all European Union Directives and Regulations since novel
foods and processes is an aspect of food law that is harmonized throughout the EU.
Responsible UK authorities
1. The Health and Safety Executive (HSE) regulate genetically modified organisms (GMOs) in
contained use (e.g., in a laboratory) HSE
2. The Department for Environment, Food & Rural Affairs (Defra) is responsible for the control of the
deliberate release of GMOs, and for national, EU and international policy on the environmental safety
of GMOs. Defra
Defra is the competent authority that implements and enforces Directive 2001/18/EC of the European
Parliament and of the Council of 12 March 2001 on the deliberate release into the environment of
genetically modified organisms. EU Directive 2001/18/EC
Defra provides the secretariat for the Advisory Committee on Releases to the Environment (ACRE).
ACRE is the independent body which reviews applications for field trials of organisms. Defra/ACRE
3. The Food Standards Agency (FSA) controls the assessment of GM food for human consumption
(food and feed), and consumer labeling of GM foods. FSA
The FSA is advised on both GM and novel foods by an independent body of experts called the Advisory
Committee on Novel Foods and Processes (ACNFP) and on GM animal feed by the Advisory
Committee on Animal Feedingstuffs (ACAF). The ACNFP is responsible for assessing the safety of
novel and GM food, and ACAF is responsible for assessing the safety of GM feed.
Recent statements by Secretary of State for Environment, Food, and Rural Affairs
It is clear from recent statements made by Owen Paterson, Secretary of State for Environment, Food,
and Rural Affairs, that the UK government is determined to make progress on this issue. Continued
economic difficulties for the UK and the likelihood of negotiations starting on a Transatlantic Trade and
Investment Partnership between the U.S. and the EU have made a stronger political case for access to
biotechnology. The UK has some of the largest and most efficient farms in Europe, but recent extreme
weather events and a reduction in available fungicides and pesticides (as a result of an EU review) has
left horticultural production vulnerable. The UK is keen to attract inward investment in plant science
applications and capitalize on any growth opportunities presented by biotechnology.
Excerpts from recent media coverage:
- 10 -
Owen Paterson: “Genetically modified food should be grown and sold widely in Britain and consumer
opposition to the technology is a complete nonsense”
Source: Telegraph 9 Dec 2012
“Downing Street said it was working behind the scenes to encourage European Commission officials to
make it easier for farmers to grow GM crops.”
Source: Telegraph 10 Dec 2012
Owen Paterson: "We should not be afraid of making the case to the public about the potential benefits
of GM beyond the food chain - for example, reducing the use of pesticides and inputs such as diesel. I
believe that GM offers great opportunities but I also recognize that we owe a duty to the public to
reassure them that it is a safe and beneficial innovation."
Source: Guardian 3 Jan 2013
Owen Paterson: "Every year we delay, Argentina, Brazil and Canada are getting further ahead of us,"
he said. "We are mad not to seriously look at this technology."
Source: Farmers Weekly 8 Feb 2013
Political attention on food security, climate change, population growth concerns and adoption of a
policy to pursue sustainable intensification of agricultural production has paved the way for greater
acceptance of biotechnology. The quotation “It’s another tool in the tool-box of technologies we need
to feed more and impact less” has gained traction to such a degree that it forms part of the UK
government's Department for Environment, Food & Rural Affairs (Defra) policy statement on biotech
“The Government recognizes that GM technology could deliver benefits providing it is used safely and
responsibly, in particular as one of a range of tools to address the longer term challenges of global food
security, climate change, and the need for more sustainable agricultural production. Developing
countries should have fair access to such technology and make their own informed decisions regarding
To encourage innovation, fair market access for safe products and economic growth, the Government
believes that regulation of this technology must be proportionate.”
The UK government makes decisions on a science and evidence base. It considers each new biotech
dossier submitted to the European Food Safety Authority (EFSA) on a case by case basis. The UK's
independent Advisory Committee on Releases to the Environment (ACRE) and Advisory Committee on
Novel Foods and Processes (ACNFP) review each relevant application made to EFSA and their
- 11 -
opinions guide UK policy.
UK tends to adopt a pro-trade, pro-science, principled and pragmatic approach in EU negotiations on
biotechnology. Increasingly frustrated by the slow EU approval process for new biotech events,
particularly for cultivation, the UK government (as with most thorny EU issues) seeks to partner with
other like-minded European Member States to effect change. However, the centre of gravity at EU level
seems to be weighted towards those Member States politically opposed to the technology. Without a
serious political shift in Member States with large voting weights, such as France, Germany, and to a
lesser extent Italy, there is no prospect of achieving the Qualified Majority needed to shorten approval
times (around 46 months currently for food and feed dossiers).
The exceptionally wet weather in the UK in summer 2012 highlighted the need for progressive plant
science to tackle fungal disease in domestic horticulture, particularly potatoes. Defra’s policy statement
also states: “The Government supports farmers having access to developments in new technology and
being able to choose whether or not to adopt them.” Increasingly, the UK’s considerable plant science
research base is seen as an area of Life Sciences that is critical to the UK’s economic growth and
employment. A prioritized agenda for laboratory and field work, applicable to the needs of farmers and
growers, adequately supported by agricultural extension services, is also now seen as vital to increase
UK self-reliance in food and agricultural commodities. If biotechnology is the means by which a
particular outcome and agronomic or quality benefit can safely and most economically be achieved,
then the UK government’s current stance indicates likely support for commercial cultivation.
As part of the UK Industrial Strategy announced by the Secretary of State for Business, Innovation and
Skills in September 2012, the UK is developing a long-term agri-tech strategy focused on knowledge
transfer and the application of technology to the agricultural sector. A public comment period ran from
October to November 2012, and an initial indication of its scope is expected by mid 2013.
Role and membership of the Biosafety Committee
The UK has ratified the Cartagena Protocol on Biosafety. Defra is the contact point, see:
The enforcement of this regulation has been implemented in England by way of the Genetically
Modified Organisms (Transboundary Movements) (England) Regulations 2004 . Similar regulations
have been implemented in Scotland, Northern Ireland and Wales).
Biological Diversity is an increasing area of work for the UK government, as agricultural innovation
seeks to increase production while at the same time reducing environmental and biodiversity impacts.
- 12 -
Biodiversity 2020 – A strategy for England’s wildlife and ecosystem was launched in 2011.
Increasingly, countries with experience of growing biotechnology crops will be asked how they measure
the impact of monoculture/short rotation on wildlife, and for hard statistical results.
The United Kingdom is comprised of England, Wales, Scotland and Northern Ireland. The devolved
governments of Northern Ireland, Scotland and Wales have jurisdiction over agriculture, fisheries, and
food policy in their regions. Scotland and Wales are countries with a high proportion of “Less Favored
Areas” for agriculture under EU Common Agricultural Policy definitions and they trade heavily on their
‘pristine environment’ image. The political leadership of Scotland and Wales continues to seek the
most restrictive policies possible on agricultural biotechnology, including the set up of “GM-free
zones”. Similarly, Northern Ireland joined forces with the Republic of Ireland to call for Ireland to
become a “GM-free zone” in September 2008. These more rural communities generally feel that
growing biotech crops risks damaging the reputation of produce from Scotland, Wales and Ireland that
outweighs any benefits that agricultural biotechnology might bring.
In formulating overall UK biotechnology policy, central government (based in London) solicits views
from a wide range of stakeholders, including the devolved Parliaments.
Approvals for food/feed and cultivation
The procedures for gaining EU approval for the import of biotech food or animal feed, and also seeds
for cultivation are detailed in our EU report here: GAIN Database link to FR9105
Since the EU livestock industry, particularly pigs and poultry, require an external source of protein-rich
animal feed, import authorizations for food and feed (which go hand in hand) intended to supply that
market are usually approved when trade becomes critical. However, approvals for both food/feed and
cultivation are slower than intended under EU law. Cultivation dossiers have taken notoriously long
times to pass, with the last approval taking over 13 years for a non-edible potato. According to
EuropaBio, the European trade association for the biotech industry, cumulative delay in EU approval of
biotech products now amounts to 44 years, see: EuropaBio summary of delays
Biotechnology Crops Approved for Commercial Use
The full list of approved products for feed and food use under Regulation EC 1829/2003, and cultivation
(environmental release) under Directive 2001/18 is available at: Europa GM Register.
The approval process for stacked events (more than one trait) is the same as for single events.
Field testing of biotechnology crops
- 13 -
As covered earlier in this report, the UK has currently only one field trial of wheat that has been
modified to produce a non-toxic odor that repels aphids. Having had only one year of results, it is too
early to predict a possible time to commercialization for this trait.
There are no pending applications for additional field trials. Applications are listed Defra website GM
Field trials must provide a grid reference for sites for which there is an active consent for a biotech trial
release. Details are posted on the Defra website trials page.
Coexistence between biotech and non-biotech crops (including organic agriculture)
The UK government’s policy statement says: “If and when GM crops are grown in England
commercially, we will implement pragmatic and proportionate measures to segregate these from
conventional and organic crops, so that choice can be exercised and economic interests appropriately
The basis for any UK coexistence policy is likely to be the extensive work carried out by SCIMAC
(Supply Chain Initiative on Modified Agricultural Crops). Information on their proposals for
coexistence and liability can be found here: SCIMAC
The EU’s labeling requirements are intended to address consumer concerns, and are not related to
safety. Labeling regulations for products containing or consisting of Genetically Modified Organisms
(GMOs) are presented in Regulation (EC) No 1830/2003, article 4B. In general, these labeling
regulations apply to bulk agricultural commodities, such as whole grains and oilseeds. The scope of
biotech products covered is defined in Directive 2001/18, see: Eur-Lex Europa.
Labeling regulations for food and feed products that are produced from GMOs are presented in
Regulation (EC) No 1829/2003, articles 12-13 for food, and articles 24-25 for feed. These are for
products that have undergone varying degrees of processing. In general, all food and feed products
containing/consisting of GMOs and/or produced from GMOs, including products that no longer contain
detectable traces of GMOs, must be labeled. The allowable adventitious presence level for EU-approved
varieties of GMOs for use in food and feed is set at 0.9 percent. Above this level, all products must be
As the EU's authorization procedures for new biotech varieties tend to be slower than those of other
countries, a time-lag known as 'asynchronous authorization' occurs. To deal with the possible presence
of unauthorized varieties in imports of commodity crops, the EU has adopted a measure, Regulation
619/2011, which sets a tolerance level of 0.1 percent for certain varieties for which a valid application
for an EU authorization has been made and which fulfill the requirements set out in Article 2 of the
- 14 -
Above this threshold, the product is not allowed on the EU market. Operators must demonstrate that the
presence of GM material was adventitious or technically unavoidable.
The EU’s Joint Research Centre has published guidance on the application of Regulation (EU) No
EU regulations do not require labeling of products that are not food ingredients, such as
processing aids. In addition, meat, milk or eggs obtained from animals fed with GM feed or treated with
GM medicinal products do not require GM labeling.
Example of to How to Label for Food Produced from GMOs
Article 13 of Regulation 1829/2003 specifies the wording to be used on the label as follows:
(a) Where the food consists of more than one ingredient, the following wording must follow
immediately after the ingredient concerned, in brackets: "genetically modified" or "produced from
genetically modified [name of ingredient]. A compound ingredient with a constituent X which is
produced from a GMO Y must be labeled "contains X produced from genetically modified Y. Example:
a biscuit containing soy flour derived from GM-soy must be labeled "contains soy flour from genetically
(b) Where the ingredient is designated by the name of a category, the following wording must be used in
the list of ingredients: "contains genetically modified [name of organism]" or "contains [name of
ingredient] produced from genetically modified [name of organism]". Example: for vegetable oils
containing rape oil produced from genetically modified rape, the reference "contains rape oil from
genetically modified rape" must appear in the list of ingredients.
(c) Where there is no list of ingredients, the words "genetically modified" or "produced from genetically
modified [name of organism]" must appear clearly in the labeling. Example 1: "a spirit containing
caramel produced from genetically modified corn". Example 2: "genetically modified sweet corn"
(d) If the product consists of or contains a GMO, e.g., sweet corn in a Mexican salad, the label must
state "genetically modified sweet corn"
The designations in (a) and (b) may appear in a footnote to the ingredients list, provided they are printed
in a font at least the same size as that of the list of ingredients or, where there is no list of ingredients,
clearly on the labeling.
- 15 -
Labeling for Genetically Modified Microorganisms (GMMs) and “Processing Aids”
Food and feed (including food and feed ingredients, such as additives, flavorings and vitamins)
produced by fermentation using a GMM which is kept under contained conditions and is not present in
the final product are not included in the scope of Regulation (EC) No. 1829/2003. These food and feed
products are considered as having been produced with the GMM, rather than from the GMM.
Therefore, these products do not have to be labeled like products produced from agricultural
biotechnology. Likewise in the case of GMMs such as yeast used in alcoholic beverages, the EU does
not require labeling if the GMM is not present in the final food. This is also true of cheese that has been
produced “with” the use of chymosin, an enzyme that is genetically modified. Such processing aids do
not fall within the scope of the labeling regulations.
In the UK, traceability and labeling regulations are the responsibility of the Food Standards Agency.
UK information on GM food and feed labeling can be found at: FSA Labelling.
Seed Labeling Legislation
In the absence of any EU seed labeling regulation for the adventitious presence of biotech seed, the
European Commission has advised that any seed lot containing GM seed authorized for the cultivation
has to be labeled as containing GMOs. Seed lots containing GM seeds that are not authorized for
cultivation cannot be marketed in the EU.
In the UK, this is enforced by the GM Inspectorate of the Food and Environment Research Agency
(Fera). In the coming year the GM Inspectorate will focus on minimizing the risk of adventitious GM
presence in conventional seeds of Brassica napus, Brassica rapa, Glycine max and Zea mays. For more
information see: GM Inspectorate.
Section IV. Plant Biotechnology Marketing Issues:
There are signs that the ground is shifting in the UK. The trade and even mainstream journalism are
increasingly making a case for the technology and calling on industry and the public to be more open-
minded about potential benefits. There is a growing awareness that European consumers are buying
- 16 -
meat from animals fed on biotech feed, and a growing acceptance that biotech crop derivatives in the
food supply chain are inevitable, and to be managed, if not embraced.
Numerous opinion polls and consumer surveys have been carried out in relation to British consumer
acceptance, or otherwise, of biotech food. There is a vocal minority against, but most surveys report
apathy and a lack of knowledge by the general population, who rely heavily on supermarket chains to
provide them with safe, quality food. There is a dominance of private label products in the UK market
and an inherent trust (cultivated by the retailers) that they will “do the right thing” for their customers.
Since all of the retail chains publicly declared their private label to be “GM free” in the early 2000s very
few biotech derived ingredients/products have made it onto British shelves.
As the number and adoption of biotech products worldwide continues to increase exponentially,
availability and the cost of sourcing and segregating biotech products has become a real issue for the
UK supply chain. No single retailer wants to be the first to undo their previous general stance on
biotechnology. However, movement has been necessary on the animal feed side as the availability of
non-biotech has rapidly decreased and the cost increased. Asda (Walmart) and Wm Morrisons
Supermarkets were the first to move to acceptance of biotech feed for their private label meat and
poultry products around two years ago. In April 2013, Tesco, Cooperative Group, Marks & Spencer,
and Sainsbury Supermarkets also communicated to their customers that from May 2013 the poultry and
livestock supply chains could no longer source sufficient quantities of non-biotech animal feed at a
reasonable cost. Organic options are available for those who wish to avoid biotech-fed livestock, and
the up-scale Waitrose chain (capitalizing on the opportunity to differentiate from its competitors) now
requires non-biotech feed for both its poultry and pig meat products.
There have been recent calls by lobby groups to label biotech-fed meat and poultry products (currently
exempt from EU labeling law). Some commentators believe that voluntary labeling will help
acceptance of biotech feed and food, since the labeling will be become familiar. Others cite concerns
that biotech-fed meat and poultry products will be seen as the option for the poorest in society, while the
richest will have alternatives. However, it is more likely, if given the information and a choice, UK
consumers will vote with their wallets and pocket books.
UK Consumer Research into Attitudes and Acceptance of Biotech foods
A selection of available research:
Food Standards Agency Consumer Research on GM and Novel Foods
- 17 -
British Science Association Reports
Institute of Grocery Distribution Factsheet
European Crop Protection Association
The food price spikes of 2008 and ensuing debate and focus on how to deliver global food security,
while addressing climate change and feeding a burgeoning population resulted in more positive media
coverage for biotechnology. This, together with the economic downturn and a need for the UK
government to support areas that will create economic growth and skilled labor, has created a more
favorable policy environment for biotechnology. This may create more confidence in the food retail and
manufacturing base to incorporate biotech derivatives in mainstream grocery products. As alluded to
earlier, the majority of consumers look to supermarket chains to determine the quality/price ratio and to
rigorously check the safety of the food they purchase.
Section V. Plant Biotechnology Capacity Building and Outreach:
After almost a decade of minimal outreach on biotechnology, the Office of Agricultural Affairs in
London renewed their attention on this area as the food security/climate change/ population growth
debate grew on the back of the food price spikes of 2008-2009. In September 2010, a one-day
conference was hosted using part U.S. Department of State and part internal Foreign Agricultural
Service (FAS) funding. This has been followed up with several speaking engagements for State’s
Bureau of Economic and Business Affairs' (EB) staff, again utilizing part agricultural biotechnology
outreach funds and part internal FAS funding.
The International Visitors Leadership Program (IVLP) has also provided a valuable opportunity to send
British contacts to the U.S. on tailored biotechnology or broader agriculture programs.
Section VI. Animal Biotechnology:
Genetic modifications and enhancements in animals “are much further away from commercial
application in food production” (British Society of Animal Science) compared to plants. Research is
the main focus of biotech animals in the UK.
Laws have been implemented since the 1980’s to better control and regulate genetic manipulation in
- 18 -
animals and protect the citizens of the UK. The Animal Scientific Procedures Act was passed in 1986,
which required strict scientific and ethical justifications for procedures and experiments on animals. In
1994 the UK government created a committee to advise the government on issues dealing with the
ethical issues of biotech animals. Although selective breeding for preferable genetic traits has been
occurring since the 18th century (Health and Safety Executive), “both the creation of genetically
modified organisms, and breeding from them, are controlled procedures already in the UK, requiring a
license from the Secretary of State. Before a license is granted, the likely 'adverse effects' on the animal
have to be weighed against the likely benefits of the modification” (British Society of Animal Science).
These strict requirements make it inefficient and expensive for genetically modified animals to be used
for commercial and agricultural purposes. However, research is ongoing to advance the use of
genetically modified animals for agriculture and pharmaceuticals. For example, cows have been
genetically engineered to produce milk that is drinkable for people who suffer from lactose intolerance,
as well as milk that is high in the fatty acids found in fish. In 2011, the universities of Cambridge and
Edinburgh announced that they had created a biotech chicken that will not pass on the avian influenza
virus to other birds. This protects the flock and could potentially increase production output. Research
into agricultural and food-based applications of biotechnology is funded by the Biotechnology and
Biological Sciences Research Council (BBSRC).
Defra, the Department for Environment, Food and Rural Affairs, plays an overarching role in the
regulation of genetically enhanced animals. The Health and Safety Executive helps to control the
contained use of genetically modified organisms in the United Kingdom to make sure that no products
or animals are released or exposed to humans without safety inspections and approvals.
The National Centre for the Replacement, Refinement and Reduction of Animals in Research is an
independent scientific organization. Tasked by the UK government, they support the science base by
facilitating and funding innovation and technological developments that replace or reduce the need for
animals in research and testing, and lead to improvements in welfare where animals continue to be
used. This also includes work to reduce, refine and replace GM animals.
Currently, no GM animals or derived products are on the EU market. However, the European Food
Safety Authority (EFSA) has started to look at this area with a view to informing EU policy decisions.
Sources of information on Animal Biotechnology:
Defra GM Page
HSE Biosafety Law
- 19 -
HSE Biosafety GMO Information
British Society of Animal Science
National Centre for Reduction of Animals in Research
EU Food Safety Authority
- 20 -